Therapy of Autoimmune Liver Disease

The principle of therapy for chronic inflammatory liver diseases is the removal of causal agents. For autoimmune liver diseases, however, total removal of causal agents and immune cells is impossible. Therefore, autoimmune liver diseases are presently treated by suppression of the immune response. Autoimmune hepatitis is characteristically responsive to corticosteroids, often used in combination with azathioprine to obtain a steroid-sparing effect. For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment. 

  • Autoimmune cholangitis
  • Autoimmune liver Disease
  • Liver Transplantation

Related Conference of Therapy of Autoimmune Liver Disease

November 21-22, 2019

World Conference on Vaccine and Immunology

MENA Plaza Hotel Albarsha | Dubai, UAE
November 21-22, 2019

14th International Conference on Allergy and Clinical Immunology

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
December 02-03, 2019

10th International Conference on Immunology & Immunogenetics

Park Inn by Radisson Hotel & Conference Centre London
June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
September 14-15, 2020

35th World Congress on Immunology

Tokyo, Japan
Oct 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
October 19-20, 2020

lifestylemanagment-cs-2020

Amsterdam, Netherlands

International Conference on Immunology & Immunotherapies

November 18-19, 2020 | Bangkok, Thailand
November 25-26, 2020

International Conference On European Immunology

London, UK

Therapy of Autoimmune Liver Disease Conference Speakers

Recommended Sessions

Related Journals

Are you interested in